title: Cost-effectiveness of RespiGam at a university teaching hospital.
authors.forename: M
authors.initials: M
authors.lastname: Veerman
authors.forename: P
authors.initials: P
authors.lastname: Reuman
authors.forename: D
authors.initials: D
authors.lastname: Burchfield
authors.forename: J
authors.initials: J
authors.lastname: Sherman
mesh_terms: D003362:Cost-Benefit Analysis; D005431:Florida; D006776:Hospitals, Pediatric; D006785:Hospitals, University; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics*; D007223:Infant; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses; D012307:Risk Factors
chemical_list: D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous